|Bid||0.000 x 0|
|Ask||0.000 x 0|
|Day's Range||31.680 - 31.730|
|52 Week Range||25.250 - 36.820|
|PE Ratio (TTM)||21.76|
|Dividend & Yield||1.03 (3.26%)|
|1y Target Est||N/A|
Announcement: Moody's: Yestar's 1 H 2017 results support its Ba3 ratings. Global Credit Research- 17 Aug 2017. Hong Kong, August 17, 2017-- Moody's Investors Service says that Yestar Healthcare Holdings ...
Ophthotech (OPHT) disappoints with poor evaluation of Fovista combined with Eylea or Avastin for treatment of AMD in phase III. The study misses the primary endpoint.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Roche Holding AG Here are 5 ETFs with the largest exposure to RHHBY-US. Comparing the performance and risk of Roche Holding AG with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)